This inventor holds 1 USPTO granted patent. Top assignee: Gilead Sciences, Inc.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Ramin Farzaneh-Far: Innovator in Hypertrophic Cardiomyopathy Treatment
Introduction
Ramin Farzaneh-Far is a notable inventor based in Redwood City, CA. He has made significant contributions to the field of medicine, particularly in the treatment of hypertrophic cardiomyopathy. His innovative approach has the potential to improve the lives of many patients suffering from this condition.
Latest Patents
Ramin holds a patent for "Methods of treating hypertrophic cardiomyopathy." This patent involves a compound of formula (I) or formula (II) or a pharmaceutically acceptable salt thereof, aimed at treating hypertrophic cardiomyopathy. His work in this area is crucial for advancing therapeutic options available to patients.
Career Highlights
Ramin is currently employed at Gilead Sciences, Inc., a leading biopharmaceutical company. His role at Gilead allows him to work on cutting-edge research and development projects that focus on innovative treatments for serious health conditions.
Collaborations
Ramin collaborates with Luiz Belardinelli, a fellow professional in the field. Their partnership enhances the research efforts at Gilead Sciences, Inc., contributing to the development of new therapies.
Conclusion
Ramin Farzaneh-Far is a dedicated inventor whose work in hypertrophic cardiomyopathy treatment exemplifies innovation in the medical field. His contributions are paving the way for improved patient care and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile